Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
19.26
+0.33 (1.77%)
At close: Nov 4, 2026, 4:00 PM EST
19.22
-0.04 (-0.18%)
After-hours: Nov 4, 2026, 7:03 PM EST
Viatris Employees
Viatris had 30,000 employees as of June 30, 2026. The number of employees decreased by 2,000 or 6.25% compared to the same quarter last year. That makes Viatris the 1,242nd largest employer in the world and 324th in the United States.
Employees
30,000
Change (1Y)
-2,000
Growth (1Y)
-6.25%
Revenue / Employee
$491,243
Profits / Employee
-$13,690
Market Cap
22.12B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 30,000 | -2,000 | -6.25% |
| Dec 31, 2025 | 30,000 | -2,000 | -6.25% |
| Dec 31, 2024 | 32,000 | -6,000 | -15.79% |
| Dec 31, 2023 | 38,000 | 1,000 | 2.70% |
| Dec 31, 2022 | 37,000 | 0 | - |
| Dec 31, 2021 | 37,000 | -8,000 | -17.78% |
| Dec 31, 2020 | 45,000 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,029 |
| Teva Pharmaceutical Industries | 33,950 |
| Dr. Reddy's Laboratories | 27,527 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Neurocrine Biosciences | 2,500 |
VTRS News
- 12 hours ago - Viatris Announces Quarterly Dividend - PRNewsWire
- 5 days ago - Viatris commences tender offer to acquire Pacira for $36.50 per share in cash - TheFly
- 5 days ago - Viatris commences tender offer to acquire Pacira for $36.50 per share in cash - TheFly
- 5 days ago - Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc. - PRNewsWire
- 9 days ago - Viatris price target raised to $14 from $13 at Piper Sandler - TheFly
- 14 days ago - Viatris price target raised to $20 from $18 at JPMorgan - TheFly
- 19 days ago - Viatris announces FDA approval of ryzumvi for treatment of presbyopia in adults - TheFly
- 19 days ago - Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia - PRNewsWire